The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

UL16-binding proteins (ULBPs) belong to a family of ligands for NKG2D activating receptor of human natural killer (NK) cells. We previously reported that RAET1E2, a soluble isoform of the RAET1E (ULBP4), inhibits NKG2D-mediated NK cytotoxicity. In this study, we examined whether ULBP4 could be recognized by gammadeltaT cells via TCRgammadelta. Here we show that immobilized soluble ULBP4 (rULBP4) induces the proliferation of human ovarian epithelial carcinoma- or colonic carcinoma-derived Vdelta2(+) T cells in vitro. These Vdelta2(+) T cells secrete Th1 cytokines and display a strong cytolytic activity toward ULBP4-transfected targets. We also show that ULBP4 binds to a soluble chimeric protein containing TCRgamma9/delta2 and activates TCR(-) Jurkat T cells transfected with TCRgamma9/delta2. Moreover, both TCRgammadelta and NKG2D are involved in ULBP4-induced activation and cytotoxicity of gammadeltaT cells. We found that ULBP4 is expressed not only on human tumor cells, but also on Epstein-Barr virus (EBV)-infected peripheral blood cells. Taken together, our data suggest that ULBP4 functions as a ligand for both TCRgammadelta and NKG2D and may play a key role in immune surveillance of tumor development and clearance of viral infection.

[1]  Chi Ma,et al.  Four novel ULBP splice variants are ligands for human NKG2D. , 2008, International immunology.

[2]  Hongbin He,et al.  Identification of Human T Cell Receptor γδ-recognized Epitopes/Proteins via CDR3δ Peptide-based Immunobiochemical Strategy* , 2008, Journal of Biological Chemistry.

[3]  B. Schermer,et al.  Extracellular Phosphorylation of Collagen XVII by Ecto-Casein Kinase 2 Inhibits Ectodomain Shedding* , 2007, Journal of Biological Chemistry.

[4]  B. Wollenberg,et al.  Lysis of a Broad Range of Epithelial Tumour Cells by Human γδ T Cells: Involvement of NKG2D ligands and T‐cell Receptor‐ versus NKG2D‐dependent Recognition , 2007 .

[5]  Chi Ma,et al.  RAET1E2, a Soluble Isoform of the UL16-binding Protein RAET1E Produced by Tumor Cells, Inhibits NKG2D-mediated NK Cytotoxicity* , 2007, Journal of Biological Chemistry.

[6]  M. Gobbi,et al.  Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins. , 2007, Blood.

[7]  M. Bonneville,et al.  Self/non‐self discrimination by human γδ T cells: simple solutions for a complex issue? , 2007 .

[8]  J. Trowsdale,et al.  Regulation of NKG2D ligand gene expression. , 2006, Human immunology.

[9]  Hui Chen,et al.  Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences. , 2006, Biochemical and biophysical research communications.

[10]  D. Kabelitz,et al.  Activation of Vγ9Vδ2 T Cells by NKG2D1 , 2005, The Journal of Immunology.

[11]  M. Gobbi,et al.  Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by Trans-Retinoic Acid , 2004, Cancer Research.

[12]  J. Trowsdale,et al.  Two Human ULBP/RAET1 Molecules with Transmembrane Regions Are Ligands for NKG2D1 , 2004, The Journal of Immunology.

[13]  M. Espéli,et al.  Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors , 2004, European journal of immunology.

[14]  D. Raulet.  Roles of the NKG2D immunoreceptor and its ligands , 2003, Nature Reviews Immunology.

[15]  L. Cui,et al.  Immobilized MICA Could Expand Human Vδ1 γδ T Cells In Vitro that Displayed Major Histocompatibility Complex Class I Chain‐Related A‐Dependent Cytotoxicity to Human Epithelial Carcinomas , 2003 .

[16]  H. Jomaa,et al.  A genetic basis for human gammadelta T-cell reactivity towards microbial pathogens. , 2003, Trends in immunology.

[17]  P. Leibson,et al.  NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway , 2003, Nature Immunology.

[18]  C. Sutherland,et al.  ULBP4 is a novel ligand for human NKG2D. , 2003, Biochemical and biophysical research communications.

[19]  Jeffrey M. Vinocur,et al.  LETAL, A Tumor-Associated NKG2D Immunoreceptor Ligand, Induces Activation and Expansion of Effector Immune Cells , 2003, Cancer biology & therapy.

[20]  T. Spies,et al.  T Cell Antigen Receptor Engagement and Specificity in the Recognition of Stress-Inducible MHC Class I-Related Chains by Human Epithelial γδ T Cells1 , 2002, The Journal of Immunology.

[21]  M. Bonneville,et al.  Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules. , 2001, Microbes and infection.

[22]  T. Spies,et al.  MICA Engagement by Human Vγ2Vδ2 T Cells Enhances Their Antigen-Dependent Effector Function , 2001 .

[23]  Wei He,et al.  Antitumor Activity of Expanded Human Tumor-Infiltrating γδ T Lymphocytes , 2001, International Archives of Allergy and Immunology.

[24]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[25]  M. Bonneville,et al.  A chemical basis for recognition of nonpeptide antigens by human γδ T cells* , 2000 .

[26]  A. Krensky,et al.  Self-Recognition of Cd1 by γ/δ T Cells , 2000, The Journal of experimental medicine.

[27]  M. Sitkovsky,et al.  Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? , 1999, Trends in pharmacological sciences.

[28]  Jun Wu,et al.  An activating immunoreceptor complex formed by NKG2D and DAP10. , 1999, Science.

[29]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[30]  Yoshimasa Tanaka,et al.  Recognition of nonpeptide prenyl pyrophosphate antigens by human γδ T cells , 1999 .

[31]  T. Spies,et al.  Diversification, expression, and γδ T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules , 1998 .

[32]  S. Bauer,et al.  Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. , 1998, Science.

[33]  S. Carr,et al.  Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin‐binding fibroblast growth factor receptor tyrosine kinase (flg) , 1993, Protein science : a publication of the Protein Society.

[34]  K. Pfeffer,et al.  A lectin-binding, protease-resistant mycobacterial ligand specifically activates V gamma 9+ human gamma delta T cells. , 1992, Journal of immunology.

[35]  T. Hercend,et al.  Subpopulations of human peripheral T gamma delta lymphocytes. , 1989, Immunology today.

[36]  M. Sitkovsky,et al.  A novel cytotoxic T lymphocyte activation assay. Optimized conditions for antigen receptor triggered granule enzyme secretion. , 1987, Journal of immunological methods.

[37]  Hongbo Hu,et al.  γδ T cells recognize tumor cells via CDR3δ region , 2007 .

[38]  B. Monsarrat,et al.  Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. , 2005, Immunity.

[39]  Michael J. Wilson,et al.  A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. , 2002, Genomics.

[40]  A. Hayday.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection. , 2000, Annual review of immunology.